Arbutus Biopharma
Price & Volume
Stats
See more52W Range | $2.21-$4.72 |
Market Cap | $608.2M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $6.7M |
Revenue Growth (YoY) | -71.3% |
Gross Profit (12 Mos) | -$45.3M |
Diluted EPS | -$0.43 |
News
See moreYahoo Finance • last year
Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD
Yahoo Finance • last year
Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®
Yahoo Finance • last year
Arbutus to Present at Jefferies London Healthcare Conference
Yahoo Finance • last year
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update
About
CEO | Mr. Michael J. McElhaugh |
CFO | Mr. David C. Hastings CPA |
Address | 701 Veterans Circle, Warminster, PA, United States, 18974 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 73 |
